Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
The Trials and Tribulations of the US Academic and Government End-Market in 2025: Presentation Highlights from the 44th JPMorgan Healthcare Conference
On February 7, 2025, the Trump administration announced a 15% cap on all indirect costs for new and existing NIH grants. However, on April 4, 2025, the US District Court in Massachusetts enacted a preliminary injunction blocking the limit. In response, the HHS appealed the injunction to the US Court of Appeals for the First […]
Single Use Leads Bioreactor Market Growth
A new report from Strategic Directions International (SDi), a business intelligence firm specializing in the analytical instrument market, finds that the compound annual growth rate (CAGR) between 2024 and 2029 of demand in the cell and gene therapy (C>) market for seven categories of analytical technologies will expand in the high single digits. The technology […]
10x Genomics Debuts First Plate-Based Assay
10x Genomics has begun shipping its latest Flex assay for its Chromium instrument platform, responding to the needs of the single-cell sequencing market for easy to use, higher-throughput and scalable solutions. For example, the burgeoning field of cell atlases, or maps of an organism’s cells, requiring larger data sets and thus the faster generation of […]
Lab Tool Companies and Share Repurchases
Share repurchase programs have been a heavily discussed topic among investors and analysts, with some questioning their relationship to a company’s financial health. Among the leading reasons companies initiate share repurchase programs is to reduce the number of outstanding shares, thereby increasing the value of the remaining shares. Additionally, companies buy back shares to demonstrate […]
Precision Cell Systems: Bringing Companies Together to Share Resources
As the life science analytical instrument industry faces the challenges presented by uncertain government and academic funding and slower CapEx spending by biopharma companies, plus nervousness from potential investors, companies introducing new technology for life science research are facing a more difficult environment for raising money. Formed earlier this year, Precision Cell Systems (PCS) is […]